Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.
Feature | Magnetic Resonance Imaging (MRI) | February 16, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) used...
News | Contrast Media | February 07, 2018
February 7, 2018 — The American College of Radiology (ACR) introduced a new...
News | Contrast Media | January 30, 2018
January 30, 2018 — Bracco Diagnostics Inc. announced the labeling of its...
Sponsored Content
A volume of contrast agent lingers near the injection site, creating an artifact that can block the visualization of structures. Graphic courtesy of Lior Molvin
Blog | Contrast Media | October 15, 2019
When it comes to listing needs, patient safety ranks at the top. Just ask an imaging administrator.
News | Contrast Media | January 19, 2018
January 19, 2018 — Ligand Pharmaceuticals Inc. announced initiation of a program to develop...
Blog | RSNA 2017 | January 18, 2018 | Dave Fornell
The Radiological Association of North America's (RSNA) 2017 conference will be remembered as the year artificial...
MR images through, A, C, E, basal ganglia and, B, D, F, posterior fossa at level of dentate nucleus. Images are shown for, A, B, control group patient 4, and the, C, D, first and, E, F, last examinations performed in contrast group patient 13. Regions of interest used in quantification of signal intensity are shown as dashed lines for globus pallidus (green), thalamus (blue), dentate nucleus (yellow), and pons (red).
News | Contrast Media | January 11, 2018
January 11, 2018 — There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive...
Sponsored Content
Characteristics nephrologists associate with renal high-risk patients. (n=13)
Feature | Contrast Media | September 05, 2019
The global rise in chronic disease has significantly increased demand for diagnostic imaging procedures, and in turn,
News | Cardiac Imaging | January 09, 2018
January 9, 2018 – Competitive male triathletes face a higher risk of a potentially harmful heart condition called...
Videos | Magnetic Resonance Imaging (MRI) | December 19, 2017
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of...
The FDA issued new warnings on MRI gadolinium contrast agents.
Feature | Magnetic Resonance Imaging (MRI) | December 19, 2017
The U.S. Food and Drug Administration (FDA) announced in a new drug safety communication is this week that it is...
Sponsored Content
Power injectors can improve efficiency and patient safety, for example, ensuring that contrast agent is not wasted due to the lack of a saline bolus. Image courtesy of Lior Molvin
Blog | Contrast Media | July 31, 2019
Injector technology development carries on the evolution of contrast agents
Gadolinium-based contrast agents (GBCAs) used in MRI causes gadolinium retention in the brain, skin and bone. However, there have not been any large-scale studies to determine if this presents long-term patient safety issues.
Blog | Magnetic Resonance Imaging (MRI) | December 15, 2017 | Dave Fornell
Over the past couple years covering the news about gadolinium-based contrast agent (GBCA) retention in the brain, skin...
Technology | Contrast Media | December 12, 2017
December 12, 2017 — Brainlab announced U.S. Food and Drug Administration (FDA) clearance of its Contrast Clearance...
Technology | Contrast Media | December 11, 2017
December 11, 2017 — Sectra recently announced the global introduction of gadolinium tracking in its dose monitoring...
Sponsored Content
Image courtesy of Lior Molvin
Blog | Contrast Media | July 15, 2019
Contrast agents improve every kind of medical image from computed tomography (CT) to magnetic resonance imaging (MR),
Videos | Magnetic Resonance Imaging (MRI) | December 07, 2017
Max Wintermark, M.D., professor of radiology and chief of neuroradiology, Stanford Hospital and Clinics, discussed MRI...
News | Contrast Media | October 10, 2017
October 10, 2017 — Guerbet announced it will be taking part in the 65th edition of the Journées Francophones de...
Image courtesy of Bayer
Feature | Contrast Media | October 04, 2017 | By Dave Fornell
Over the past decade, several clinical studies have shown gadolinium-based...
News | Contrast Media | September 12, 2017
September 12, 2017 — The U.S. Food and Drug Administration’s (FDA) Medical Imaging Drugs Advisory Committee (MIDAC)...
News | Contrast Media | September 07, 2017
September 7, 2017 — The U.S. Food and Drug Administration (FDA) held a meeting of the Medical Imaging Drugs Advisory...
Technology | Magnetic Resonance Imaging (MRI) | September 06, 2017
September 6, 2017 — Guerbet LLC USA announced that the U.S. Food and Drug Administration (FDA) has approved Dotarem (...
News | Contrast Media | August 29, 2017
August 29, 2017 — The European Medicines Agency (EMA) issued a final opinion that recommended restricting the use of...
News | Contrast Media | August 15, 2017
August 15, 2017 — The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the...
